Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

by · The Cerbat Gem

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report published on Saturday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE opened at $0.00 on Friday. The business’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.01. The stock has a market capitalization of $2,383.50, a PE ratio of 0.00 and a beta of 3.78. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $1.99.

About Ampio Pharmaceuticals

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Read More